Description du projet
Un nouveau produit de biocontrôle contre les mycotoxines est prêt à être commercialisé
Les mycotoxines produites par les champignons qui se développent dans les cultures céréalières sont une menace persistante pour la santé humaine, mais aucune solution durable et efficace n’est disponible de nos jours. L’aflatoxine produite par des espèces d’Aspergillus fungus constitue une menace particulière. Le projet FREEMYCO a identifié un produit de biocontrôle efficace et mène une étude de faisabilité pour le commercialiser. Les chercheurs d’Ideagro ont identifié une souche du champignon Trichoderma koningiopsis, qui contrôle la prérécolte d’Aspergillus et d’autres champignons producteurs de mycotoxines, à la fois pour l’agriculture organique et conventionnelle. Le produit a été testé de manière approfondie et s’est avéré efficace in vitro. FREEMYCO évaluera la viabilité commerciale, technique et économique du plan commercial, testera le produit in vivo et formulera un produit final destiné aux marchés commerciaux.
Objectif
Mycotoxins are toxic molecules produced by different fungal strains such as Aspergillus, Fusarium and Penicillium that mainly affect grains both in the pre and postharvest stages. One of them, aflatoxin, is one of the most hazardous toxins for human health, and till date there is no solution to control it through a sustainable way. Ideagro is a 9-year experienced company which main activity is R&D focused on the agrifood sector. Our R&D efforts have found that a Trichoderma koningiopsis strain fungus (IDE-Tri1) is able to control the aforenamed fungi and toxins in cereals crops in a preharvest stage. Thus, in the wake of these investigation works, FREEMYCO is born as the unique bio-fungicide active substance that have shown its absolute effectiveness for Aspergillus fungi and consequently aflatoxin in cereal crops during pre-harvest stage, for both conventional and organic agriculture. It will be able to control also remaining mycotoxins which are less harmful. controlling the mycotoxins, as it has been successfully tested through in vitro and in vivo tests. FREEMYCO is a great economic opportunity (cumulative profit of €11.47M in three years after its launching) to take advantages of a natural product for facing a serious problem for agriculture, food quality/security and human health in a sustainable way. Our target customers are the largest phytosanitary producers’ firms. We consider that through a B2B business approach we will be successful to penetrating into the highly competitive global bio-pesticide market and ensure our product selling. This Feasibility Study’s goal is to deepen in those key points to assess the economic, technical and commercial viability of FREEMYCO (including in vivo trial and end final product formulation) to tackle this challenge for us to scale-up.
Champ scientifique
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
30564 LORQUI
Espagne
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.